Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c
February 15, 2022 4:05 PM EST
SEATTLE, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Adaptive Biotechnologies) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2021.
We finished the year strong with revenue increasing 57% year over year, driven by growth in both our sequencing and development revenue categories, said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies. As we move into 2022, I am encouraged by the momentum and the... More
